Acturadar.comFrance in real time

Detected on Sunday 1 November, 17h57

Besançon University Hospital launches €6 million fundraiser for its UCPVax vaccine

Besançon University Hospital has announced a €6 million fundraiser to continue clinical trials of UCPVax, a therapeutic vaccine against several cancers.

In brief

Health event (severity: low) in Besançon (Doubs), first detected on 1 November 2026 at 17:57. Reported by 1 source (1 article), last updated on 1 November 2026 at 17:57.

·
Category
Health
Severity
Low
Place
25 DoubsBesançon
Detected
1 Nov, 17h57
Updated
1 Nov, 17h57
Reference
no.6749
01

Who is covering it, and from what angle

Method
1Uncategorised

1 article · 1 source · no rated outlet covers this topic yet (public service, agencies, official accounts…)

Angle comparison

A comparison is written as soon as the event is covered by at least two sides (left, centre, right).

02

Lire les sources · 1 article, 1 source

Publication order
  1. 17h57
    France 3 RégionsWire1 Nov
    "J'ai retrouvé l'espoir" : un vaccin thérapeutique pour soigner le cancer, l'UCPVax a besoin de 6 millions d'euros pour continuer les essais cliniques

    Le 20 octobre, le CHU de Besançon a annoncé une levée de fonds à hauteur de six millions d'euros pour continuer à développer l'UCPVax. Ce vaccin thérapeutique a fait ses preuves dans le traitement de plusieurs cancers et a le potentiel de sauver de nombreuses vies.

03

Further reading

Reported toll

Amounts cited6 millions d'euros · six millions d'euros

Highest number recorded in 1 article(s), automatically extracted: please check sources.

Organisations cited

Places cited

Keywords

#vaccin thérapeutique · #cancer · #CHU de Besançon · #levée de fonds

Go up the thread

Affected departments

People and organisations cited